Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results
TLDR
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results, however, no differences have been found in terms of impact factor.Abstract:
Objectives
Publication bias may affect the validity of evidence based medical decisions. The aim of this study is to assess whether research outcomes affect the dissemination of clinical trial findings, in terms of rate, time to publication, and impact factor of journal publications.
Methods and Findings
All drug-evaluating clinical trials submitted to and approved by a general hospital ethics committee between 1997 and 2004 were prospectively followed to analyze their fate and publication. Published articles were identified by searching Pubmed and other electronic databases. Clinical study final reports submitted to the ethics committee, final reports synopses available online and meeting abstracts were also considered as sources of study results. Study outcomes were classified as positive (when statistical significance favoring experimental drug was achieved), negative (when no statistical significance was achieved or it favored control drug) and descriptive (for non-controlled studies). Time to publication was defined as time from study closure to publication. A survival analysis was performed using a Cox regression model to analyze time to publication. Journal impact factors of identified publications were recorded. Publication rate was 48·4% (380/785). Study results were identified for 68·9% of all completed clinical trials (541/785). Publication rate was 84·9% (180/212) for studies with results classified as positive and 68·9% (128/186) for studies with results classified as negative (p<0·001). Median time to publication was 2·09 years (IC95 1·61–2·56) for studies with results classified as positive and 3·21 years (IC95 2·69–3·70) for studies with results classified as negative (hazard ratio 1·99 (IC95 1·55–2·55). No differences were found in publication impact factor between positive (median 6·308, interquartile range: 3·141–28·409) and negative result studies (median 8·266, interquartile range: 4·135–17·157).
Conclusions
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results. However, no differences have been found in terms of impact factor.read more
Citations
More filters
Posted ContentDOI
Multimodal imaging improves brain age prediction and reveals distinct abnormalities in patients with psychiatric and neurological disorders
Jaroslav Rokicki,Thomas Wolfers,Wibeke Nordhøy,Natalia Tesli,Daniel Quintana,Dag Alnæs,Geneviève Richard,Ann-Marie Glasø de Lange,Martina J. Lund,Linn B. Norbom,Ingrid Agartz,Ingrid Melle,Terje Nærland,Geir Selbæk,Geir Selbæk,Karin Persson,Jan Egil Nordvik,Emanuel Schwarz,Ole A. Andreassen,Tobias Kaufmann,Lars T. Westlye +20 more
TL;DR: The findings demonstrate that multidimensional phenotyping provides a mapping of overlapping and distinct pathophysiology in common disorders of the brain, and specifically suggest metabolic and neurovascular aberrations in SZ and at-risk and early stage dementia.
Journal ArticleDOI
Distance metrics for ranked evolutionary trees.
TL;DR: This work introduces metrics on ranked tree shapes and ranked genealogies, in which the shape and temporal branching order in a tree are considered, but not the taxon labels, which enable quantification of evolutionary differences, assessment of tree uncertainty, and construction of statistical summaries of a tree distribution.
Journal ArticleDOI
Investigations of a Cretaceous limestone with spectral induced polarization and scanning electron microscopy
Sara Johansson,Charlotte Sparrenbom,Gianluca Fiandaca,Anders Lindskog,Per-Ivar Olsson,Torleif Dahlin,Håkan Rosqvist +6 more
TL;DR: Sara Johansson, Charlotte Sparrenbom, Gianluca Fiandaca, and Håkan Rosqvist as discussed by the authors presented a survey of the state of the art in the field of Geology at the University of Lund in Sweden.
Journal ArticleDOI
Complete Genome Sequence for the Shellfish Pathogen Vibrio coralliilyticus RE98 Isolated from a Shellfish Hatchery
TL;DR: Books on strain RE98 list it as a Vibrio tubiashii; however, whole genome sequencing confirms RE98 as V. coralliilyticus, a pathogen of corals and larval shellfish.
Journal ArticleDOI
Blocking of targeted microRNAs from next-generation sequencing libraries
Brian S. Roberts,Andrew A. Hardigan,Marie K. Kirby,Meredith B. Fitz-Gerald,C. Mel Wilcox,Robert P. Kimberly,Richard M. Myers +6 more
TL;DR: In human plasma samples, it is demonstrated that blocking of highly abundant hsa-miR-16–5p leads to improved detection of lowly expressed miRNAs and more precise measurement of differential expression overall.
References
More filters
Journal ArticleDOI
Pharmacological interventions for somatoform disorders in adults.
Maria Kleinstäuber,Michael Witthöft,Andrés Steffanowski,Harm W.J. van Marwijk,Wolfgang Hiller,Michael J. Lambert +5 more
TL;DR: A systematic review and meta-analysis of placebo-controlled studies examined the efficacy and tolerability of different types of antidepressants, the combination of an antidepressant and an antipsychotic, antipsychotics alone, or natural products in adults with somatoform disorders in adults to improve optimal treatment decisions.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement.
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and should provide the reader with the ability to make informed judgments regarding the internal and external validity of the trial.
Journal ArticleDOI
Publication bias in clinical research
TL;DR: The presence of publication bias in a cohort of clinical research studies is confirmed and it is suggested that conclusions based only on a review of published data should be interpreted cautiously, especially for observational studies.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and accurate and complete reporting is needed.
Journal ArticleDOI
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
TL;DR: The reporting of trial outcomes is not only frequently incomplete but also biased and inconsistent with protocols and Published articles, as well as reviews that incorporate them, may therefore be unreliable and overestimate the benefits of an intervention.